Bringing the fundamentals into focus…
Back to Kiniksa Pharmaceuticals International, plc
How Kiniksa Pharmaceuticals International, plc stacks up
KNSA · against 1,216 other Healthcare companies
Growth
97/ 100
Near the top of its peers.
Ranked #32 of 1,217 · scores higher than 97% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including KNSA · Click a bar to see the companies
Why growth scores 97?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth, 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- faster revenue growth over three years: stronger than 92% of peers. 3-year revenue growth: 44.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 92% of peers. Revenue growth: 58.9% vs peer median 6.1%
- faster growth in earnings per share: stronger than 99% of peers. Earnings per share growth: 1473.7% vs peer median 9.8%
Metric by metric
Position: dot = KNSA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KNSA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 58.9% | 6.1% | 92% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 1473.7% | 9.7% | 99% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 44.1% | 5.8% | 92% | 33% |
Ranking by growth score
Top 5 and the companies ranked around KNSA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 32 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 32 | 21.4B USD | 97 | 67 | |
| 32 | 4.0B USD | 97 | 56 | |
| 32 | 110M USD | 97 | 38 | |
| 32 | 7.3B USD | 97 | 74 | |
| 32 | 4.4B AUD (≈$2.9B) | 97 | 51 | |
| 39 | 534.0B KRW (≈$385M) | 96 | 59 | |
| 39 | 10.8B JPY (≈$73M) | 96 | 27 | |
| 39 | 56.7B USD | 96 | 79 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score